Exercise Limitation in Patients with Chronic Obstructive Pulmonary Disease at the Altitude of Bogota (2640 m). Breathing Pattern and Arterial Gases at Rest and Peak Exercise;Limitación a la Tolerancia al Ejercicio en Pacientes con EPOC a la Altura de Bogotá (2.640 m). Patrón Respiratorio y Gasometría Arterial en Reposo y en Ejercicio Pico

Archivos de Bronconeumologia

Volumn 40, Issue 2, 2004, Pages 54-61

  Gonzalez Garcia M ^a,b   Barrero, M ^a   Maldonado, D ^a  

^a FUNDACIÓN NEUMOLÓGICA COLOMBIANA   (Colombia)

^b NONE   (Colombia)

Author keywords

Altitude; Arterial blood gases; Breathing pattern; Chronic obstructive pulmonary disease; Dynamic hyperinflation; Exercise

Indexed keywords

ADULT; AGED; ALTITUDE; ARTERIAL GAS; ARTICLE; BICYCLE ERGOMETER; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COLOMBIA; CONTROLLED STUDY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOXEMIA; INSPIRATORY CAPACITY; LUNG MINUTE VOLUME; MALE; OXYGEN CONSUMPTION; TIDAL VOLUME;

EID: 12144286461     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056709     Document Type: Article

References (42)

1. O'Donell DE. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. En: Weisman IM, Zeballos R, editors. Clinical exercise testing. Basilea: Karger, 2002; p. 138-58.
2. Nici L. Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med 2000;2:693-704.
3. Gallagher CG. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary diseases. Clin Chest Med 1994;15:305-26.
4. Agusti AGN, Cotes J, Wagner PD. Responses to exercise in lung disease. En: Roca J, Whipp BJ, editors. Clinical exercise testing. European Respiratory Monograph. ERS 1997;2:32-50.
5. Acevedo LE, Solarte I. Gasimetría arterial en adultos sanos a nivel de Bogotá. Acta Médica Colombiana 1984;9:7-14.
6. Roa J, De Arroyo S, Salcedo MC, Maldonado D. Gasimetría arterial a diferentes edades en Bogotá. Acta Médica Colombiana 1988;13(Supl):415A.
7. Pierson DJ. Pathophysiology and clinical effects of chronic hypoxia. Respir Care 2000;45:39-51.
8. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part one. Am J Respir Crit Care Med 1994;150:833-52.
9. ATS. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
10. American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor). Am J Respir Crit Care Med 1995;152:2185-98.
11. Hansen JE, Sue DY, Waserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984;129:S49-S55.
12. rd ed. Philadelphia: Lippincott Williams Wilkins, 1999; p. 143-64.
13. Roca J, Burgos F, Casan P, Ortega F, Puente-Maestu L, Togores B. Normativa SEPAR. Pruebas de ejercicio cardiopulmonar. Arch Bronconeumol 2001;37:247-68.
14. Zeballos R, Weisman IM. Behind the scenes of cardiopulmonary exercise testing. Clin Chest Med 1994;15:193-213.
15. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81.
16. Johnson BD, Weisman IM, Zeballos RJ, Beck KC. Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest 1999;116:488-503.
17. Dolmage T, Goldstein R. Repeatebility of inspiratory capacity during incremental exercise in patients with severe COPD. Chest 2002;121:708-14.
18. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1997;156:55-9.
19. Marín J, Carrizo S, Gascón M, Sánchez A, Gallego B, Celli B. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1395-9.
20. O'Donell DE, D'Arsigny, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:892-8.
21. Snider GL. Enhancement of exercise performance in COPD patients with hyperoxia. Chest 2002:122:1830-6.
22. Díaz O, Villafranca H, Ghezzo H, Borzone G, Leiva A. Millic-Emili J. et al. Breathing pattern and gas exchange at peak exercise in COPD patients with and without flow limitation at rest. Eur Respir J 2001;17:1120-7.
23. Milic-Emili J, Grunstein MM. Drive and timing components of ventilation. Chest 1976;70:131-3.
24. Lind FG, Truve AB, Linborg BPO. Microcomputer-assisted online measurement of breathing pattern and occlusion pressure. J Appl Physiol 1984:56:235-9.
25. Lederer DH, Altose MD, Kelsen SG, Cherniack NS. Comparison of occlusion pressure and ventilatory responses. Thorax 1977;32:212-20.
26. Begin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Respis Dis 1991;143:905-12.
27. De Troyer A, Leeper JB, McKenzie DK, Gandevia SC. Neural drive to the diaphragm in patients with severe COPD. Am J Respir Crit Care Med 1997;155:1335-40.
28. Light RW, Mahutte CK, Brown SE. Etiology of carbon dioxide retention ay rest and during exercise in chronic airflow obstruction. Chest 1988;94:61-7.
29. O'Donell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557-65.
30. O'Donell DE, Revill SM, Weeb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:770-7.
31. LoRusso TJ, Belman MJ, Elashoff JD. Prediction of maximal exercise capacity in obstructive and restrictive pulmonary disease. Chest 1993;104:1748-58.
32. Montes de Oca M, Rassulo J, Celli B. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996;154:1284-9.
33. Light RW, Mintz WM, Linden GS, Brow SE. Hemodinamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise. Am Rev Respir Dis 1998;130:391-5.
34. Mathay RA, Berger HJ, Davies RA, Loke J, Mahler DA, Gottschalk A, et al. Right and left ventricular exercise performance in chronic obstructive pulmonary disease: radionuclide assessment. Ann Inter Med 1980;93:234-9.
35. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1988;113:576-83.
36. Agustí AG, Barbera JA, Roca J, Wagner PD, Guitart R, Rodríguez-Rasin R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990;97:268-75.
37. Bedu M, Giraldo H, Janicot H, Fellmann N, Coudert J. Interaction between cold and hypoxia on pulmonary circulation in COPD. Am J Respir Crit Care Med 1996;153:1247-7.
38. Wagner PD. Ventilation-perfusion matching during exercise. Chest 1992;101:192S-8S.
39. Maltais F, Leblanc P, Simard C. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:442-7.
40. American Thoracic Society/European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999;159(Suppl):1-40.
41. Gosselink, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976.
42. Maltais F, LeBlanc P, Jobin J, Casabury R. Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med 2000;21:665-77.